Chris Hyde

Summary

Publications

  1. doi request reprint Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model
    Christopher Hyde
    PCMD, University of Exeter, PenTAG, Veysey Building Salmon Pool Lane, Exeter, Devon EX2 4SG, UK
    Age Ageing 42:14-20. 2013
  2. pmc The acute management of trauma hemorrhage: a systematic review of randomized controlled trials
    Nicola Curry
    NHS Blood and Transplant, Oxford Radcliffe Hospitals NHS Trust and University of Oxford, Headley Way, Oxford, OX3 9BQ, UK
    Crit Care 15:R92. 2011
  3. pmc A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients
    Tristan Snowsill
    Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK
    BMC Cancer 15:313. 2015
  4. pmc The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model
    Louise Crathorne
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 20:1-588. 2016
  5. pmc A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer
    Nicola Huxley
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 19:v-xxv, 1-215. 2015
  6. pmc A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
    Tristan Snowsill
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 18:1-406. 2014
  7. doi request reprint Evolution of a cost-utility model of donepezil for Alzheimer's disease
    Jaime L Peters
    PenTAG, University of Exeter, UK
    Int J Technol Assess Health Care 29:147-54. 2013
  8. pmc What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
    Linda Long
    Peninsula Technology Assessment Group PenTAG, Evidence Synthesis and Modelling for Health Improvement ESMI, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 19:1-134. 2015
  9. doi request reprint Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding
    Harriet Hunt
    Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK
    Cochrane Database Syst Rev 2:CD010438. 2015
  10. doi request reprint Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer
    Martin Hoyle
    Peninsula Technology Assessment Group PenTAG, Medical School, University of Exeter, Exeter, UK
    Value Health 16:288-96. 2013

Collaborators

  • Martin Hoyle
  • Jaime L Peters
  • Sarah Davis
  • Tristan Snowsill
  • Nicola Huxley
  • Chris Cooper
  • Helen Coelho
  • Tracey Jones-Hughes
  • Louise Crathorne
  • Linda Long
  • Nicola Curry
  • Rubén Mújica-Mota
  • Simon Briscoe
  • Harriet Hunt
  • Ian Frayling
  • Simon Stanworth
  • Mark Napier
  • Marcela Haasova
  • Antonieta Medina-Lara
  • Obioha Ukoumunne
  • Tom Woolley
  • Yang Meng
  • Zhivko Zhelev
  • Sally Hopewell
  • Karim Brohi
  • Carolyn Doree

Detail Information

Publications10

  1. doi request reprint Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model
    Christopher Hyde
    PCMD, University of Exeter, PenTAG, Veysey Building Salmon Pool Lane, Exeter, Devon EX2 4SG, UK
    Age Ageing 42:14-20. 2013
    ..in 2007 the National Institute of Health and Clinical Excellence (NICE) restricted the use of acetylcholinesterase inhibitors and memantine...
  2. pmc The acute management of trauma hemorrhage: a systematic review of randomized controlled trials
    Nicola Curry
    NHS Blood and Transplant, Oxford Radcliffe Hospitals NHS Trust and University of Oxford, Headley Way, Oxford, OX3 9BQ, UK
    Crit Care 15:R92. 2011
    ....
  3. pmc A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients
    Tristan Snowsill
    Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK
    BMC Cancer 15:313. 2015
    ..The objective of this project was to estimate the cost-utility of strategies to identify Lynch syndrome in individuals with early-onset colorectal cancer in the NHS...
  4. pmc The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model
    Louise Crathorne
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 20:1-588. 2016
    ..Erythropoiesis-stimulating agents (ESAs) are licensed for use in conjunction with red blood cell transfusions to improve cancer treatment-induced anaemia (CIA)...
  5. pmc A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer
    Nicola Huxley
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 19:v-xxv, 1-215. 2015
    ....
  6. pmc A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
    Tristan Snowsill
    Peninsula Technology Assessment Group PenTAG, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 18:1-406. 2014
    ..Lynch syndrome (LS) is an inherited autosomal dominant disorder characterised by an increased risk of colorectal cancer (CRC) and other cancers, and caused by mutations in the deoxyribonucleic acid (DNA) mismatch repair genes...
  7. doi request reprint Evolution of a cost-utility model of donepezil for Alzheimer's disease
    Jaime L Peters
    PenTAG, University of Exeter, UK
    Int J Technol Assess Health Care 29:147-54. 2013
    ....
  8. pmc What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
    Linda Long
    Peninsula Technology Assessment Group PenTAG, Evidence Synthesis and Modelling for Health Improvement ESMI, University of Exeter Medical School, Exeter, UK
    Health Technol Assess 19:1-134. 2015
    ..The condition is challenging to treat and prone to recurrent episodes. The average duration of a typical episode ranges from 6 to 24 months, with most (89%) reporting recovery by 1 year...
  9. doi request reprint Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding
    Harriet Hunt
    Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK
    Cochrane Database Syst Rev 2:CD010438. 2015
    ..In some centres, thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are standard tests, but in the UK they are more commonly used in research settings...
  10. doi request reprint Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer
    Martin Hoyle
    Peninsula Technology Assessment Group PenTAG, Medical School, University of Exeter, Exeter, UK
    Value Health 16:288-96. 2013
    ....